Published in:
01-02-2021 | Dysphonia | Letter to the Editors
Unexpected ketamine effect in a patient with cervical dystonia
Authors:
Cecilia Nencini, Vincenzo De Santis, Maurizio Fusari
Published in:
Journal of Neurology
|
Issue 2/2021
Login to get access
Excerpt
Cervical dystonia is the most common form of adult-onset focal dystonia [
1‐
3]. It is a highly disabling disorder that negatively impacts quality of life. Chemodenervation of affected muscles with botulinum toxin injections is a first-line treatment for most forms of focal dystonia, but the response can vary and reinjections are required every 3 months [
4]. Other treatment options are largely symptomatic and empiric. Ketamine is a non-selective N-methyl-
d-aspartate (NMDA) antagonist with anesthetic, analgesic and anticonvulsant properties that has also been safely administered for the treatment of major depressive disorder, post-traumatic stress disorder and chronic pain states [
5]. …